Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26FXTY6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,973
Award facts
- Contract value 100% obligated
- $6,973.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,973.34 to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/mL auto-injector on January 14, 2026, with an ultimate completion date of February 5, 2026. This firm fixed-price, competitively awarded contract carries no set-aside designation. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. BENLYSTA (belimumab) is a monoclonal antibody used to treat systemic lupus erythematosus and lupus nephritis, representing the type of specialized therapeutic medication that falls within the broader scope of the DLA's medical supply chain operations. The company's extensive federal contract portfolio demonstrates consistent capability to fulfill open competition procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FXTY6?
SPE2DR26FXTY6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FXTY6 worth?
The government has obligated $6,973 on SPE2DR26FXTY6.
Is contract SPE2DR26FXTY6 an order under another contract?
Yes. SPE2DR26FXTY6 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXTY6 competed?
The extent of competition for SPE2DR26FXTY6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award